ONTOZRY-150mg/28 (Cenobamate Tablet) 150 mg

ONTOZRY (Cenobamate) 150 mg tablets are prescribed for epilepsy management. This anticonvulsant helps reduce seizure frequency in adults. Store at room temperature and follow your doctor’s guidance. Always consult a healthcare professional before use.

Strength

150 mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

ARVELLE THERAPEUTICS

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ONTOZRY (Cenobamate) 150 mg tablets are used to control seizures in adults with epilepsy. It is typically prescribed when other treatments have not been effective. This medication belongs to a class of drugs known as anticonvulsants, which work by stabilizing electrical activity in the brain. It is not intended for immediate seizure relief but as part of long-term management.

Side Effects

ONTOZRY (Cenobamate) 150 mg tablets may help reduce the number and severity of seizures over time. Some users report improved daily functioning and fewer disruptions to their routine. Like all medications, individual responses vary, and effects may take time to become noticeable. Regular use as directed is important for best results.

Precautions & Warnings

Keep ONTOZRY (Cenobamate) 150 mg tablets in a cool, dry place away from children and pets. Do not use if the packaging is damaged or the tablets appear altered. Inform your healthcare provider about all medications and supplements you are taking before starting this treatment. Store at room temperature and avoid exposure to extreme heat or moisture.

Avoid Interactions

ONTOZRY (Cenobamate) 150 mg tablets may interact with other central nervous system depressants, such as alcohol or sedatives. It can also affect the way your liver processes certain medications, so inform your doctor about all drugs you are using. Avoid combining with other anticonvulsants without medical supervision. Always discuss potential interactions with a healthcare professional.

Frequently Asked Questions

ONTOZRY (Cenobamate) 150 mg tablets are used to reduce seizure frequency in adults with epilepsy.

Store ONTOZRY 150 mg tablets at room temperature in a dry place, away from direct light and children.

Consult your doctor before combining ONTOZRY with other medications, as interactions may occur.

Effects may take several weeks to become noticeable; follow your prescribed schedule consistently.

ONTOZRY is not classified as a controlled substance but should be used only as directed by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.